Massive Bio is building the world's largest global real time cancer registry with patient consented clinical and genomic data.
Massive Bio has raised $16.5M in total funding. The most recent round was Series A. The last funding was announced in June 2022.
Massive Bio's investors include 500 Global, Revo Capital, KFW DEG, SiteGround, ImpactAssets.
Massive Bio is headquartered in Boca Raton, United States.
Massive Bio is building the world's largest global real time cancer registry with patient consented clinical and genomic data.
Massive Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Massive Bio — Funding & Investors." VCBacked, June 2, 2022, https://www.vcbacked.co/company/massive-bio. Accessed September 29, 2026.
VCBacked. (2022). Massive Bio — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/massive-bio
{{cite web |title=Massive Bio — Funding & Investors |url=https://www.vcbacked.co/company/massive-bio |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated